Vivos Therapeutics, Inc. Adjustments to Additional Paid in Capital, Other
Vivos Therapeutics, Inc. (VVOS) reported Adjustments to Additional Paid in Capital, Other of $731.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2025-03-31
- Vivos Therapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2021-03-31 was $231.72K.
- Vivos Therapeutics, Inc. adjustments to additional paid in capital, other for fiscal 2023 was $731.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|
| 2023-12-31 | $731.00K 10-K · filed 2025-03-31 | |
| 2021-03-31 | $231.72K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |